Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.

Kadota K, Villena-Vargas J, Yoshizawa A, Motoi N, Sima CS, Riely GJ, Rusch VW, Adusumilli PS, Travis WD.

Am J Surg Pathol. 2014 Apr;38(4):448-60. doi: 10.1097/PAS.0000000000000134.

PMID:
24472852
[PubMed - indexed for MEDLINE]
2.

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.

Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MG, Park BJ, Rusch VW, Travis WD.

Mod Pathol. 2011 May;24(5):653-64. doi: 10.1038/modpathol.2010.232. Epub 2011 Jan 21.

PMID:
21252858
[PubMed - indexed for MEDLINE]
Free Article
3.

Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma.

Kadota K, Nitadori J, Sarkaria IS, Sima CS, Jia X, Yoshizawa A, Rusch VW, Travis WD, Adusumilli PS.

Cancer. 2013 Mar 1;119(5):931-8. doi: 10.1002/cncr.27863. Epub 2012 Oct 23.

PMID:
23096929
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.

Tsutani Y, Miyata Y, Mimae T, Kushitani K, Takeshima Y, Yoshimura M, Okada M.

J Thorac Cardiovasc Surg. 2013 Sep;146(3):580-5. doi: 10.1016/j.jtcvs.2013.04.032. Epub 2013 Jun 15.

PMID:
23778085
[PubMed - indexed for MEDLINE]
5.

Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.

Yoshizawa A, Sumiyoshi S, Sonobe M, Kobayashi M, Fujimoto M, Kawakami F, Tsuruyama T, Travis WD, Date H, Haga H.

J Thorac Oncol. 2013 Jan;8(1):52-61. doi: 10.1097/JTO.0b013e3182769aa8.

PMID:
23242438
[PubMed - indexed for MEDLINE]
6.

Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.

Takahashi M, Shigematsu Y, Ohta M, Tokumasu H, Matsukura T, Hirai T.

J Thorac Cardiovasc Surg. 2014 Jan;147(1):54-9. doi: 10.1016/j.jtcvs.2013.08.058. Epub 2013 Oct 13.

PMID:
24131786
[PubMed - indexed for MEDLINE]
7.

Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.

Xu L, Tavora F, Battafarano R, Burke A.

Am J Surg Pathol. 2012 Feb;36(2):273-82. doi: 10.1097/PAS.0b013e31823b3eeb.

PMID:
22198010
[PubMed - indexed for MEDLINE]
8.

FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.

Kadota K, Colovos C, Suzuki K, Rizk NP, Dunphy MP, Zabor EC, Sima CS, Yoshizawa A, Travis WD, Rusch VW, Adusumilli PS.

Ann Surg Oncol. 2012 Oct;19(11):3598-605. doi: 10.1245/s10434-012-2414-3. Epub 2012 May 30.

PMID:
22644511
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Prognostic value of the IASLC/ATS/ERS classification of lung adenocarcinoma in stage I disease of Japanese cases.

Woo T, Okudela K, Mitsui H, Tajiri M, Yamamoto T, Rino Y, Ohashi K, Masuda M.

Pathol Int. 2012 Dec;62(12):785-91. doi: 10.1111/pin.12016.

PMID:
23252867
[PubMed - indexed for MEDLINE]
10.

Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.

Song Z, Zhu H, Guo Z, Wu W, Sun W, Zhang Y.

Eur J Surg Oncol. 2013 Nov;39(11):1262-8. doi: 10.1016/j.ejso.2013.08.026. Epub 2013 Sep 11.

PMID:
24063970
[PubMed - indexed for MEDLINE]
11.

New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma.

Yanagawa N, Shiono S, Abiko M, Ogata SY, Sato T, Tamura G.

J Thorac Oncol. 2013 May;8(5):612-8. doi: 10.1097/JTO.0b013e318287c3eb.

PMID:
23584293
[PubMed - indexed for MEDLINE]
12.

The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.

Warth A, Muley T, Meister M, Stenzinger A, Thomas M, Schirmacher P, Schnabel PA, Budczies J, Hoffmann H, Weichert W.

J Clin Oncol. 2012 May 1;30(13):1438-46. doi: 10.1200/JCO.2011.37.2185. Epub 2012 Mar 5.

PMID:
22393100
[PubMed - indexed for MEDLINE]
Free Article
13.
14.

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D.

J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221. Review.

PMID:
21252716
[PubMed - indexed for MEDLINE]
15.

Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller.

Nitadori J, Bograd AJ, Kadota K, Sima CS, Rizk NP, Morales EA, Rusch VW, Travis WD, Adusumilli PS.

J Natl Cancer Inst. 2013 Aug 21;105(16):1212-20. doi: 10.1093/jnci/djt166. Epub 2013 Aug 7.

PMID:
23926067
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma.

Nitadori J, Colovos C, Kadota K, Sima CS, Sarkaria IS, Rizk NP, Rusch VW, Travis WD, Adusumilli PS.

Chest. 2013 Nov;144(5):1622-31. doi: 10.1378/chest.13-0394.

PMID:
23807749
[PubMed - indexed for MEDLINE]
17.

A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.

Kadota K, Suzuki K, Kachala SS, Zabor EC, Sima CS, Moreira AL, Yoshizawa A, Riely GJ, Rusch VW, Adusumilli PS, Travis WD.

Mod Pathol. 2012 Aug;25(8):1117-27. doi: 10.1038/modpathol.2012.58. Epub 2012 Apr 13.

PMID:
22499226
[PubMed - indexed for MEDLINE]
Free Article
18.

Distinctive histopathological features of lepidic growth predominant node-negative adenocarcinomas 3-5 cm in size.

Takahashi Y, Ishii G, Aokage K, Hishida T, Yoshida J, Nagai K.

Lung Cancer. 2013 Feb;79(2):118-24. doi: 10.1016/j.lungcan.2012.10.013. Epub 2012 Nov 21.

PMID:
23177278
[PubMed - indexed for MEDLINE]
19.

The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations.

Tsuta K, Kawago M, Inoue E, Yoshida A, Takahashi F, Sakurai H, Watanabe S, Takeuchi M, Furuta K, Asamura H, Tsuda H.

Lung Cancer. 2013 Sep;81(3):371-6. doi: 10.1016/j.lungcan.2013.06.012. Epub 2013 Jul 26.

PMID:
23891509
[PubMed - indexed for MEDLINE]
20.

Prognostic significance of the IASLC/ATS/ERS classification in Chinese patients-A single institution retrospective study of 292 lung adenocarcinoma.

Gu J, Lu C, Guo J, Chen L, Chu Y, Ji Y, Ge D.

J Surg Oncol. 2013 Apr;107(5):474-80. doi: 10.1002/jso.23259. Epub 2012 Sep 5.

PMID:
22952152
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk